Cancer Vaccines

Different Vector Enhances Booster Effect of Anti-cancer Regimen

Published in Vaccine Weekly, December 8th, 1997

The use of a different vector for boosting immunization than that used for the prime vaccination enhances the efficacy of recombinant anti-cancer vaccines in an animal model.

As one of the aims of anti-cancer vaccines is to treat established tumors, it is anticipated that several immunizations may be required. Research has shown, however, that strong host immune responses against viral proteins can inhibit the repetitive use of one vector medium.

Kari R. Irvine and colleagues from the National Cancer Institute and the National Institutes of Health, Maryland, suggested that the use of different vehicles for primary vaccination delivery and boosting...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-12-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry